Cargando…
The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients
BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after ...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494686/ https://www.ncbi.nlm.nih.gov/pubmed/34076881 http://dx.doi.org/10.1007/s40620-021-01021-1 |
_version_ | 1784579367535378432 |
---|---|
author | Lun, Zhubin Liu, Liwei Chen, Guanzhong Ying, Ming Liu, Jin Wang, Bo Liang, Jingjing Yang, Yongquan Chen, Shiqun He, Yibo Chung, Edmund Y. M. Chen, Jiyan Ye, Jianfeng Liu, Yong |
author_facet | Lun, Zhubin Liu, Liwei Chen, Guanzhong Ying, Ming Liu, Jin Wang, Bo Liang, Jingjing Yang, Yongquan Chen, Shiqun He, Yibo Chung, Edmund Y. M. Chen, Jiyan Ye, Jianfeng Liu, Yong |
author_sort | Lun, Zhubin |
collection | PubMed |
description | BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after coronary angiography. METHODS: We searched Medline, Embase, and Cochrane Database of Systematic Reviews (to 30th June 2019). We evaluated the world’s incidence of the CA-AKI, and associated mortality, and to described geographic variations according to countries, regions, and economies. CA-AKI was defined as an increase in serum creatinine ≥ 0.5 mg/dl or ≥ 25% within 72 h. Random effects model meta-analyses and meta-regressions was performed to derive the sources of heterogeneity. RESULTS: A total of 134 articles (1,211,106 participants) were included in our meta-analysis. Most studies originated from China, Japan, Turkey and United States, from upper middle income and high income countries. The pooled incidence of CA-AKI after coronary angiography was 12.8% (95% CI 11.7–13.9%), and the CA-AKI associated mortality was 20.2% (95% CI 10.7–29.7%). The incidence of CA-AKI and the CA-AKI associated mortality were not declined over time (Incidence rate change: 0.23% 95% CI − 0.050 to 0.510 p = 0.617; Mortality rate change: − 1.05% 95% CI − 3.070 to 0.970 p = 0.308, respectively). CONCLUSION: CA-AKI was a universal complication in many regions, and the burden of CA-AKI remains severe. In clinical practice, physicians should pay more attention to the occurrence and active prevention and treatment of CA-AKI. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01021-1. |
format | Online Article Text |
id | pubmed-8494686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-84946862021-10-19 The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients Lun, Zhubin Liu, Liwei Chen, Guanzhong Ying, Ming Liu, Jin Wang, Bo Liang, Jingjing Yang, Yongquan Chen, Shiqun He, Yibo Chung, Edmund Y. M. Chen, Jiyan Ye, Jianfeng Liu, Yong J Nephrol Original Article BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) is a common complication after coronary angiography (CAG), which brings a poor prognosis. But up to now, there were fewer studies to discuss the incidence of CA-AKI comprehensively. We comprehensively explore the incidence of CA-AKI after coronary angiography. METHODS: We searched Medline, Embase, and Cochrane Database of Systematic Reviews (to 30th June 2019). We evaluated the world’s incidence of the CA-AKI, and associated mortality, and to described geographic variations according to countries, regions, and economies. CA-AKI was defined as an increase in serum creatinine ≥ 0.5 mg/dl or ≥ 25% within 72 h. Random effects model meta-analyses and meta-regressions was performed to derive the sources of heterogeneity. RESULTS: A total of 134 articles (1,211,106 participants) were included in our meta-analysis. Most studies originated from China, Japan, Turkey and United States, from upper middle income and high income countries. The pooled incidence of CA-AKI after coronary angiography was 12.8% (95% CI 11.7–13.9%), and the CA-AKI associated mortality was 20.2% (95% CI 10.7–29.7%). The incidence of CA-AKI and the CA-AKI associated mortality were not declined over time (Incidence rate change: 0.23% 95% CI − 0.050 to 0.510 p = 0.617; Mortality rate change: − 1.05% 95% CI − 3.070 to 0.970 p = 0.308, respectively). CONCLUSION: CA-AKI was a universal complication in many regions, and the burden of CA-AKI remains severe. In clinical practice, physicians should pay more attention to the occurrence and active prevention and treatment of CA-AKI. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01021-1. Springer International Publishing 2021-06-02 2021 /pmc/articles/PMC8494686/ /pubmed/34076881 http://dx.doi.org/10.1007/s40620-021-01021-1 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Lun, Zhubin Liu, Liwei Chen, Guanzhong Ying, Ming Liu, Jin Wang, Bo Liang, Jingjing Yang, Yongquan Chen, Shiqun He, Yibo Chung, Edmund Y. M. Chen, Jiyan Ye, Jianfeng Liu, Yong The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title | The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title_full | The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title_fullStr | The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title_full_unstemmed | The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title_short | The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
title_sort | global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494686/ https://www.ncbi.nlm.nih.gov/pubmed/34076881 http://dx.doi.org/10.1007/s40620-021-01021-1 |
work_keys_str_mv | AT lunzhubin theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liuliwei theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenguanzhong theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yingming theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liujin theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT wangbo theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liangjingjing theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yangyongquan theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenshiqun theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT heyibo theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chungedmundym theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenjiyan theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yejianfeng theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liuyong theglobalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT lunzhubin globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liuliwei globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenguanzhong globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yingming globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liujin globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT wangbo globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liangjingjing globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yangyongquan globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenshiqun globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT heyibo globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chungedmundym globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT chenjiyan globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT yejianfeng globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients AT liuyong globalincidenceandmortalityofcontrastassociatedacutekidneyinjuryfollowingcoronaryangiographyametaanalysisof12millionpatients |